Concepedia

Chiranjeevi Pasala

CP

Statistics

Publications

12

Citations

260

H-Index

11

Active since

2016

Affiliations

Sri Venkateswara Institute of Medical Sciences(Current)

Sri Venkateswara University

Institute of Bioinformatics

Cancer Research UK

University of Cambridge

Chiranjeevi Pasala is an author at Sri Venkateswara Institute of Medical Sciences specializing in drug discovery, pharmacy, and pharmacology.

ORCID

Publications per year

2016–2024

12

Publications

12

Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations

Sudheer Kumar Katari, Pradeep Natarajan, Sandeep Swargam et al. · Journal of Receptors and Signal Transduction · 2016 · 63 citations

, , +17

Design, synthesis, anti-tobacco mosaic viral and molecule docking simulations of urea/thiourea derivatives of 2-(piperazine-1-yl)-pyrimidine and 1-(4-Fluoro/4-Chloro phenyl)-piperazine and 1-(4-Chloro phenyl)-piperazine – A study

Vadabingi Nagalakshmamma, M. Venkataswamy, Chiranjeevi Pasala et al. · Bioorganic Chemistry · 2020 · 33 citations

, , +16

An in silico study: Novel targets for potential drug and vaccine design against drug resistant H. pylori

Chiranjeevi Pasala, Chandra Sekhar Reddy Chilamakuri, Sudheer Kumar Katari et al. · Microbial Pathogenesis · 2018 · 29 citations

, , +13

Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation

Tanaya Roychowdhury, Seth McNutt, Chiranjeevi Pasala et al. · Nature Communications · 2024 · 26 citations · Full text

, , +16

Novel and potent inhibitors for dihydropteroate synthase of<i>Helicobacter pylori</i>

Sri Harsha Satuluri, Sudheer Kumar Katari, Chiranjeevi Pasala et al. · Journal of Receptors and Signal Transduction · 2020 · 20 citations

, , +17

1–5 of 12